Search

Your search keyword '"Cheol Hyeon Kim"' showing total 155 results

Search Constraints

Start Over You searched for: Author "Cheol Hyeon Kim" Remove constraint Author: "Cheol Hyeon Kim"
155 results on '"Cheol Hyeon Kim"'

Search Results

1. Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma

2. Association between thyroid cancer and epidermal growth factor receptor mutation in female with nonsmall cell lung cancer

3. Autophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790M.

4. Supplementary Data from The Role of MET Activation in Determining the Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

5. Data from The Role of MET Activation in Determining the Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

6. Supplemental material from Superior Efficacy and Selectivity of Novel Small-Molecule Kinase Inhibitors of T790M-Mutant EGFR in Preclinical Models of Lung Cancer

7. Data from Superior Efficacy and Selectivity of Novel Small-Molecule Kinase Inhibitors of T790M-Mutant EGFR in Preclinical Models of Lung Cancer

9. Data from p53 Enhances Gefitinib-Induced Growth Inhibition and Apoptosis by Regulation of Fas in Non–Small Cell Lung Cancer

10. Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors

11. Radiation Induces Autophagy via Histone H4 Lysine 20 Trimethylation in Non-small Cell Lung Cancer Cells

12. The Combination of Trametinib, a MEK Inhibitor, and Temsirolimus, an mTOR Inhibitor, Radiosensitizes Lung Cancer Cells

13. Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05

14. Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis

15. Multifocal nodular lymphoid hyperplasia of the lung

16. Altered expression of cellular proliferation, apoptosis and the cell cycle-related genes in lung cancer cells with acquired resistance to EGFR tyrosine kinase inhibitors

17. Fhit, a tumor suppressor protein, induces autophagy via 14-3-3τ in non-small cell lung cancer cells

18. Association between thyroid cancer and epidermal growth factor receptor mutation in female with nonsmall cell lung cancer

19. Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis

20. Development of a minipig model for lung injury induced by a single high-dose radiation exposure and evaluation with thoracic computed tomography

21. Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells

22. Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with

23. A Case of Kikuchi Disease Involving an Intrapulmonary Lymph Node Mistaken for a Pulmonary Nodule

24. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

25. Superior Efficacy and Selectivity of Novel Small-Molecule Kinase Inhibitors of T790M-Mutant EGFR in Preclinical Models of Lung Cancer

26. Gefitinib induces cytoplasmic translocation of the CDK inhibitor p27 and its binding to a cleaved intermediate of caspase 8 in non-small cell lung cancer cells

27. Family caregivers' awareness of illness and attitude toward disclosure during chemotherapy for advanced cancer

28. Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma

29. mTOR inhibitors radiosensitize PTEN-deficient non-small-cell lung cancer cells harboring anEGFRactivating mutation by inducing autophagy

30. Endobronchial Mycobacterium avium Infection in an Immunocompetent Patient

31. Epidermal growth factor receptor mutations and brain metastasis in patients with nonadenocarcinoma of the lung

32. Erratum

33. Epidermal growth factor receptor mutations in female patients with postoperative recurrent non-small-cell lung cancer

34. Association Between Age at Diagnosis and the Presence of EGFR Mutations in Female Patients with Resected Non-small Cell Lung Cancer

35. Age at diagnosis predicts outcomes in gefitinib-treated female patients with non-small-cell lung cancer

36. 18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: A single-institution retrospective analysis

37. Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors

38. The Role of MET Activation in Determining the Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

39. Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line

40. HIF-1α modulation by topoisomerase inhibitors in non-small cell lung cancer cell lines

41. Gastrointestinal metastasis of lung cancer with special emphasis on a long-term survivor after operation

42. What's your treatment option in a patient with impending respiratory failure due to disseminated lung cancer?

43. Presence of Malignant Mesothelial Cells in the Sputum

44. p53 Enhances Gefitinib-Induced Growth Inhibition and Apoptosis by Regulation of Fas in Non–Small Cell Lung Cancer

45. 5-(4-Chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole acts in a reactive oxygen species-dependent manner to suppress human lung cancer growth

46. alpha1-Antitrypsin genotypes in Korean patients with chronic obstructive pulmonary disease

47. Use of Complementary and Alternative Medicine among Korean Cancer Patients

48. Gemcitabine and Vinorelbine as Second-line Therapy for Non-small Cell Lung Cancer after Treatment with Paclitaxel plus Platinum

49. Aggregation of β2 integrins activates human neutrophils through the IκB/NF-κB pathway

50. Serum 25-hydroxyvitamin D levels correlate with EGFR mutational status in pulmonary adenocarcinoma

Catalog

Books, media, physical & digital resources